• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

富含甘油三酯的极低密度脂蛋白中的二氢神经酰胺与 2 型糖尿病非酒精性脂肪肝严重程度相关。

Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes.

机构信息

Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, 75006 Paris, France.

Sorbonne Université, Assistance Publique-Hôpitaux de Paris, Diabetes Department, Hospital Pitié-Salpêtrière, 75013 Paris, France.

出版信息

Cell Rep Med. 2020 Dec 22;1(9):100154. doi: 10.1016/j.xcrm.2020.100154.

DOI:10.1016/j.xcrm.2020.100154
PMID:33377125
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7762772/
Abstract

Plasma dihydroceramides are predictors of type 2 diabetes and related to metabolic dysfunctions, but the underlying mechanisms are not characterized. We compare the relationships between plasma dihydroceramides and biochemical and hepatic parameters in two cohorts of diabetic patients. Hepatic steatosis, steatohepatitis, and fibrosis are assessed by their plasma biomarkers. Plasma lipoprotein sphingolipids are studied in a sub-group of diabetic patients. Liver biopsies from subjects with suspected non-alcoholic fatty liver disease are analyzed for sphingolipid synthesis enzyme expression. Dihydroceramides, contained in triglyceride-rich very-low-density lipoprotein (VLDL), are associated with steatosis and steatohepatitis. Expression of sphingolipid synthesis enzymes is correlated with histological steatosis and inflammation grades. In conclusion, association of plasma dihydroceramides with nonalcoholic fatty liver might explain their predictive character for type 2 diabetes. Our results suggest a relationship between hepatic sphingolipid metabolism and steatohepatitis and an involvement of dihydroceramides in the synthesis/secretion of triglyceride-rich VLDL, a hallmark of NAFLD and type 2 diabetes dyslipidemia.

摘要

血浆二氢神经酰胺是 2 型糖尿病的预测因子,与代谢功能障碍有关,但潜在机制尚不清楚。我们比较了两批糖尿病患者的血浆二氢神经酰胺与生化和肝脏参数之间的关系。通过其血浆生物标志物评估肝脂肪变性、脂肪性肝炎和纤维化。在一组糖尿病患者中研究了血浆脂蛋白神经酰胺。对疑似非酒精性脂肪性肝病患者的肝活检进行神经酰胺合成酶表达分析。富含甘油三酯的极低密度脂蛋白 (VLDL) 中的二氢神经酰胺与脂肪变性和脂肪性肝炎有关。神经酰胺合成酶的表达与组织学脂肪变性和炎症程度相关。总之,血浆二氢神经酰胺与非酒精性脂肪性肝病的关联可能解释了它们对 2 型糖尿病的预测特征。我们的结果表明,肝神经酰胺代谢与脂肪性肝炎之间存在关系,并且二氢神经酰胺参与富含甘油三酯的 VLDL 的合成/分泌,这是非酒精性脂肪性肝病和 2 型糖尿病血脂异常的特征。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f1/7762772/f1dcb6792d7e/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f1/7762772/44a0a73ddfc2/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f1/7762772/7d91b58beff4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f1/7762772/285519086f27/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f1/7762772/b1280e3424ca/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f1/7762772/c40a95b29238/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f1/7762772/45e42e75de42/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f1/7762772/f1dcb6792d7e/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f1/7762772/44a0a73ddfc2/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f1/7762772/7d91b58beff4/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f1/7762772/285519086f27/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f1/7762772/b1280e3424ca/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f1/7762772/c40a95b29238/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f1/7762772/45e42e75de42/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47f1/7762772/f1dcb6792d7e/gr6.jpg

相似文献

1
Dihydroceramides in Triglyceride-Enriched VLDL Are Associated with Nonalcoholic Fatty Liver Disease Severity in Type 2 Diabetes.富含甘油三酯的极低密度脂蛋白中的二氢神经酰胺与 2 型糖尿病非酒精性脂肪肝严重程度相关。
Cell Rep Med. 2020 Dec 22;1(9):100154. doi: 10.1016/j.xcrm.2020.100154.
2
Metabolic-associated fatty liver disease and lipoprotein metabolism.代谢相关性脂肪性肝病与脂蛋白代谢。
Mol Metab. 2021 Aug;50:101238. doi: 10.1016/j.molmet.2021.101238. Epub 2021 Apr 20.
3
Thioesterase Superfamily Member 2 Promotes Hepatic VLDL Secretion by Channeling Fatty Acids Into Triglyceride Biosynthesis.硫酯酶超家族成员 2 通过将脂肪酸导入甘油三酯生物合成来促进肝脏 VLDL 分泌。
Hepatology. 2019 Aug;70(2):496-510. doi: 10.1002/hep.30411. Epub 2019 Mar 22.
4
Dihydrosphingolipids are associated with steatosis and increased fibrosis damage in non-alcoholic fatty liver disease.二氢神经酰胺与非酒精性脂肪性肝病中的脂肪变性和纤维化损伤增加有关。
Biochim Biophys Acta Mol Cell Biol Lipids. 2023 Jul;1868(7):159318. doi: 10.1016/j.bbalip.2023.159318. Epub 2023 Apr 12.
5
Sphingolipid metabolism in non-alcoholic fatty liver diseases.非酒精性脂肪性肝病中的鞘脂代谢。
Biochimie. 2019 Apr;159:9-22. doi: 10.1016/j.biochi.2018.07.021. Epub 2018 Jul 31.
6
No effect of resveratrol on VLDL-TG kinetics and insulin sensitivity in obese men with nonalcoholic fatty liver disease.白藜芦醇对非酒精性脂肪性肝病肥胖男性患者 VLDL-TG 动力学和胰岛素敏感性无影响。
Diabetes Obes Metab. 2018 Oct;20(10):2504-2509. doi: 10.1111/dom.13409. Epub 2018 Jul 5.
7
Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis.特定的肝脏神经酰胺与非酒精性脂肪性肝炎中的胰岛素抵抗、氧化应激和炎症有关。
Diabetes Care. 2018 Jun;41(6):1235-1243. doi: 10.2337/dc17-1318. Epub 2018 Mar 30.
8
Dysfunction of estrogen-related receptor alpha-dependent hepatic VLDL secretion contributes to sex disparity in NAFLD/NASH development.雌激素相关受体α依赖性肝 VLDL 分泌功能障碍导致 NAFLD/NASH 发展的性别差异。
Theranostics. 2020 Aug 29;10(24):10874-10891. doi: 10.7150/thno.47037. eCollection 2020.
9
Nonalcoholic fatty liver disease associated with metabolic syndrome: Influence of liver fibrosis stages on characteristics of very low-density lipoproteins.非酒精性脂肪性肝病与代谢综合征相关:肝纤维化分期对极低密度脂蛋白特征的影响。
Clin Chim Acta. 2017 Oct;473:1-8. doi: 10.1016/j.cca.2017.08.006. Epub 2017 Aug 9.
10
Ectodysplasin A Is Increased in Non-Alcoholic Fatty Liver Disease, But Is Not Associated With Type 2 Diabetes.外胚层发育不良相关蛋白 A 在非酒精性脂肪性肝病中增加,但与 2 型糖尿病无关。
Front Endocrinol (Lausanne). 2021 Mar 4;12:642432. doi: 10.3389/fendo.2021.642432. eCollection 2021.

引用本文的文献

1
Metabolic dysfunction-associated steatotic liver disease (MASLD) biomarkers and progression of lower limb arterial calcification in patients with type 2 diabetes: a prospective cohort study.2型糖尿病患者中代谢功能障碍相关脂肪性肝病(MASLD)生物标志物与下肢动脉钙化进展:一项前瞻性队列研究
Cardiovasc Diabetol. 2025 Apr 23;24(1):176. doi: 10.1186/s12933-025-02705-9.
2
Inverse relationship between circulating sphingosine-1-phosphate and precursor species and coronary artery calcification score in type 2 diabetes.2型糖尿病患者循环中鞘氨醇-1-磷酸及其前体物质与冠状动脉钙化评分之间的负相关关系。
Cardiovasc Diabetol. 2025 Feb 21;24(1):85. doi: 10.1186/s12933-025-02624-9.
3

本文引用的文献

1
Circulating Receptor Activator of Nuclear Factor kB Ligand and triglycerides are associated with progression of lower limb arterial calcification in type 2 diabetes: a prospective, observational cohort study.循环核因子 kappa B 受体激活物配体和甘油三酯与 2 型糖尿病下肢动脉钙化进展相关:一项前瞻性、观察性队列研究。
Cardiovasc Diabetol. 2020 Sep 18;19(1):140. doi: 10.1186/s12933-020-01122-4.
2
Hepatic Lipoprotein Export and Remission of Human Type 2 Diabetes after Weight Loss.肝脂蛋白输出与减肥后人类 2 型糖尿病的缓解
Cell Metab. 2020 Feb 4;31(2):233-249.e4. doi: 10.1016/j.cmet.2019.11.018. Epub 2019 Dec 19.
3
Oxidised Apolipoprotein Peptidome Characterises Metabolic Dysfunction-Associated Steatotic Liver Disease.
氧化载脂蛋白肽组可表征代谢功能障碍相关脂肪性肝病。
Liver Int. 2025 Feb;45(2):e16200. doi: 10.1111/liv.16200.
4
Multi-omics analysis reveals the key factors involved in the severity of the Alzheimer's disease.多组学分析揭示了阿尔茨海默病严重程度相关的关键因素。
Alzheimers Res Ther. 2024 Oct 2;16(1):213. doi: 10.1186/s13195-024-01578-6.
5
Plasma ceramides are associated with MRI-based liver fat content but not with noninvasive scores of liver fibrosis in patients with type 2 diabetes.血浆神经酰胺与基于 MRI 的肝脏脂肪含量相关,但与 2 型糖尿病患者的非侵入性肝纤维化评分无关。
Cardiovasc Diabetol. 2023 Nov 8;22(1):310. doi: 10.1186/s12933-023-02049-2.
6
Ceramide d18:1/24:1 as a potential biomarker to differentiate obesity subtypes with unfavorable health outcomes.神经酰胺 d18:1/24:1 可作为区分不良健康结局肥胖亚型的潜在生物标志物。
Lipids Health Dis. 2023 Oct 4;22(1):166. doi: 10.1186/s12944-023-01921-0.
7
Circulating Sphingolipids and Glucose Homeostasis: An Update.循环神经酰胺和葡萄糖稳态:最新进展。
Int J Mol Sci. 2023 Aug 12;24(16):12720. doi: 10.3390/ijms241612720.
8
Network-pharmacology-based research on protective effects and underlying mechanism of Shuxin decoction against myocardial ischemia/reperfusion injury with diabetes.基于网络药理学的舒心汤对糖尿病心肌缺血/再灌注损伤的保护作用及潜在机制研究
World J Diabetes. 2023 Jul 15;14(7):1057-1076. doi: 10.4239/wjd.v14.i7.1057.
9
Liraglutide reduces plasma dihydroceramide levels in patients with type 2 diabetes.利拉鲁肽可降低 2 型糖尿病患者的血浆二氢神经酰胺水平。
Cardiovasc Diabetol. 2023 May 4;22(1):104. doi: 10.1186/s12933-023-01845-0.
10
Sphingolipid desaturase DEGS1 is essential for mitochondria-associated membrane integrity.鞘脂类去饱和酶 DEGS1 对于线粒体相关膜的完整性是必需的。
J Clin Invest. 2023 May 15;133(10):e162957. doi: 10.1172/JCI162957.
The influence of ceramide and its dihydro analog on the physico-chemical properties of sphingomyelin bilayers.
神经酰胺及其二氢类似物对神经鞘磷脂双层物理化学性质的影响。
Chem Phys Lipids. 2020 Jan;226:104835. doi: 10.1016/j.chemphyslip.2019.104835. Epub 2019 Oct 21.
4
Targeting a ceramide double bond improves insulin resistance and hepatic steatosis.靶向神经酰胺双键可改善胰岛素抵抗和肝脂肪变性。
Science. 2019 Jul 26;365(6451):386-392. doi: 10.1126/science.aav3722. Epub 2019 Jul 4.
5
Alcoholic and non-alcoholic fatty liver disease: Focus on ceramide.酒精性和非酒精性脂肪性肝病:聚焦神经酰胺
Adv Biol Regul. 2018 Dec;70:40-50. doi: 10.1016/j.jbior.2018.11.004. Epub 2018 Nov 14.
6
The Physical Properties of Ceramides in Membranes.细胞膜中神经酰胺的物理性质。
Annu Rev Biophys. 2018 May 20;47:633-654. doi: 10.1146/annurev-biophys-070317-033309. Epub 2018 Apr 4.
7
Specific Hepatic Sphingolipids Relate to Insulin Resistance, Oxidative Stress, and Inflammation in Nonalcoholic Steatohepatitis.特定的肝脏神经酰胺与非酒精性脂肪性肝炎中的胰岛素抵抗、氧化应激和炎症有关。
Diabetes Care. 2018 Jun;41(6):1235-1243. doi: 10.2337/dc17-1318. Epub 2018 Mar 30.
8
Steatosis and NASH in type 2 diabetes.2 型糖尿病中的脂肪变性和 NASH。
Biochimie. 2017 Dec;143:37-41. doi: 10.1016/j.biochi.2017.10.019. Epub 2017 Oct 31.
9
Lipid environment induces ER stress, TXNIP expression and inflammation in immune cells of individuals with type 2 diabetes.脂质环境可诱导 2 型糖尿病患者免疫细胞内质网应激、TXNIP 表达和炎症反应。
Diabetologia. 2018 Feb;61(2):399-412. doi: 10.1007/s00125-017-4462-5. Epub 2017 Oct 7.
10
Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance.肝细胞因子:将非酒精性脂肪性肝病与胰岛素抵抗联系起来。
Nat Rev Endocrinol. 2017 Sep;13(9):509-520. doi: 10.1038/nrendo.2017.56. Epub 2017 Jun 9.